US2959601A - Steroidal trans-hexahydroterephthalate esters - Google Patents

Steroidal trans-hexahydroterephthalate esters Download PDF

Info

Publication number
US2959601A
US2959601A US596166A US59616656A US2959601A US 2959601 A US2959601 A US 2959601A US 596166 A US596166 A US 596166A US 59616656 A US59616656 A US 59616656A US 2959601 A US2959601 A US 2959601A
Authority
US
United States
Prior art keywords
trans
acid
water
new
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US596166A
Inventor
Allais Andre
Hoffmann Charles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Francais de Chimiotherapie SA filed Critical Laboratoires Francais de Chimiotherapie SA
Application granted granted Critical
Publication of US2959601A publication Critical patent/US2959601A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Definitions

  • This invention relates to a method of preparing new ticularly to a method of preparing acylated derivatives of steroid hormones which are distinguished by prolonged activity and by satisfactory solubility in vegetable oils which are used as the injecting medium.
  • the invention furthermore also relates to said acylated derivatives.
  • Another object of the invention is to provide a method of preparing oil soluble acylated derivatives of steroid hormones.
  • One further object of the invention is to prepare new products derived from trans-hexahydroterephthalic acid in which one of the carboxyl groups has been previously esterified.
  • Still another object of the invention is to provide new products of trans-hexahydroterephthalic acid containing the radical of a steroid hormone.
  • new acylated derivatives are obtained according to meth- 2,959,601 Patented Nov. 8, 1960 ods known per se by the reaction of acid chloride ofa hexahydroterephthalic hemiester C-OR 1 with the steroid in the resence of a tertiar bas s acylated derivatives of steroid hormones, and more'paras pyridine, methylethyl pyridine or triethylamine, etc., the operation being carried. out at room temperature or In a heated state.
  • the above noted reaction may be carried out with or without a suitable inert solvent such as benzene, toluene, ether, petroleum ether.
  • reaction mixture is taken up with a solvent which is not miscible with water, is then washed with diluted mineral” acids 'such' as HCl, H HNO or Na CO K CO carbonate or sodium of potassium bicar- Afterdrying and distillation of the solvent, new crude mixed hexahydroterephthalates are obtained which are purified by crystallization of chromatography.
  • diluted mineral acids ' such' as HCl, H HNO or Na CO K CO carbonate or sodium of potassium bicar-
  • the starting acid chlorides as above shown which heretofore were unknown in the past and serve to acylate the steroids, are obtained from hexahydroterephthalic hemiesters than can easily be produced by monosaponification of the corresponding diesters. Also, they may-be prepared with less favorable yields, by hydrogenation of the corresponding terephthalic' monoester or by monoesterification of trans-hexahydroterephthalic acid.
  • Thionyl chloride is considered most suitable for preparing the new acid chlorides. It is, of course, possible, without thereby exceeding the scope of the invention, to cause the new acid chlorides to react with a derivative of the steroid hormone and to prepare the mixed ester desired from the intermediate product obtained.
  • the new acylated derivatives maybe used dissolved in neutral vegetable oils, to which a glycol may or may not be added, or dissolved in other solvents suitable for injection purposes.
  • the variable concentrations are limited by solubility only.
  • the products, to the preparation of which the present invention relates may be used in the form of thixotropic salts which are obtained by adding monostear ate or aluminum 2-ethyl hexanoate to the oily solutions of these esters. They may also bead ministtered in the form of microcrystalline aqueous suspensions or emulsions in water, solutions in a third solvent in the presence of a neutral and non-irritating emulsifying agent.
  • the preparations are carried out by means of processes known per se.
  • transhexahydrophthalate of the steroid hormone selected and then to esterify the latter in the manner desired. It is equally possible to cause a hemiester of trans-hexahydroterephthalic acid to react with the steroid hormone in the presence of a suitable esterification catalyst thereby avoiding the use of the acid chloride.
  • the product distills completely under 0.5 mm. at 146-148 C. When cooled the distilled product crystallizes into colorless needles having the same melting point as before. It is soluble in alcohol, ether, petroleum ether, acetone, benzene and chloroform, insoluble in water, aqueous diluted acids and alkalis. This is a new compound having the following characteristics:
  • composition calculated is as follows: C, 63.1%; H, 8.8%; O, 28.9%.
  • the composition as found is as follows: C, 63.2%; H, 8.9%; O, 28.4.
  • the temperature of the bath is solwly raised from 50 to 80 in 45 minutes.
  • the excess thionyl chloride is then distilled and the distillate taken up twice with 5 cm. of anhydrous benzene, after which it is distilled.
  • the residue is constituted by 3 g.
  • the products therefore, comprise 97% of pure chloride which decomposes when its distillation is attempted. It is used, as is, for reaction with testosterone. This product is a new compound.
  • EXAMPLE 2 Preparation of the acid chloride of methyl transhexahydroterephthalate
  • Trans-hexahydroterephthalic acid such as is prepared in Example 1
  • the monosaponification of the dimethyl transhexahydroterephthalate is then carried out as above, but by treatment in methanol medium.
  • the purified herniester is caused to react, as above, with the thionyl chloride thereby producing crude acid chloride which can be used directly for condensation with testosterone.
  • composition as calculated shows C, 61.7%; H, 8.5%; O, 29.8%. As found it shows C, 61.7%; H, 8.5%; O, 29.8%.
  • composition as calculated is: C, 67.6%; H, 9.9%; O, 22.5%. As found C, 67.8%; H, 10.1%; 0, 22.7%.
  • the ethereal solution is washed with hydrochloric acid, then with sodium carbonate and finally with water until neutral. It is dried over sodium sulfate, and the ether is expelled. There results a crystallized residue melting at about 95 C. formed by the crude mixed ester. Subjected to chromatography in benzene solution over alumina, one obtains, by washing out with the same solvent, a fraction melting between 70 and 95 C. A second washing or eluate obtained with benzene comprising 10% ethyl ether melts between 100 and 110.
  • composition as calculated is: C, 74.66%; H, 9.29%; O, 16.04%.
  • composition as found is: C, 74.9%; H, 9.3%; O, 16.3%. This is a new compound.
  • testosterone propionate an equivalent dose of testosterone propionate is administered, namely, 20.8 mg.
  • the respective weights are 299, 48 and 30 mg., which proves that the new prodnot has a greater as well as more prolonged activity.
  • testosterone oenanthate always at a dose equivalent of 17 mg. of testosterone, namely, 24.1 mg. of oenanthate, the corresponding figures are 452, 514 and 465 mg. Even in this case the superiority of the new product is clearly established.
  • the combined extracts are washed with water, with N/S sodium hydroxyde, dried over magnesium sulfate and vacuum evaporated until dry.
  • the residue is taken up with 40 cm. of ethanol, to which 0.5 cm. of caustic sodium hydroxyde is added. It is then left to stand for half an hour at 20 C. then poured into water, acidified with concentrated hydrochloric acid and extracted with ether.
  • the combined ethereal extracts are dried, then evaporated until dry.
  • the chemical analysis shows the formula to be C H O whose molecular weight is 570.7.
  • composition is calculated as: C, 69.4%; H, 8.1%; O, 22.4%.
  • the composition as found: C, 69.2%; H, 8.2%; O, 22.8%.
  • n-butylic hemiester of trans-hexahydroterephthalic acid 6 cm. of thionyl chloride, the acid chloride being taken up with 7.5 cm. of benzene, and 1.5 g. of
  • prednisone, or A -dehydrocortisone, in 7.5 cm. of py-ridine are mixed together at room temperature.
  • This product which has not been described heretofore and which is new is in the form of colorless spangles or flakes. It is insoluble in water, difficultly soluble in ether, but soluble in alcohol, acetone, benzene and chloroform.
  • the chemical analysis of thecompound shows the formuIa of C H O and a molecular weight .of 568.7.
  • composition as calculated is: C, 69.7%; H, 7.8%.
  • composition as found is: C, 69.8%; H, 8.0%.
  • Example 5 The procedure herein is as in Example 5. 1 g. of methylic hemiester of trans-hexahydrotereph- 11 thalic acid prepared according to Example 2 herein, 4 cm. of thionyl chloride, the acid chloride being taken up with 5 cm. of benzene and 1 g. of testosterone in 5 cm. of pyridine are mixed together at room temperature.
  • the chemical analysis of the compound shows the formula of C H O with a molecular weight of 456.6.
  • the composition of the new compound as calculated is: C, 73.6%; H, 8.8%; O; 17.5%.
  • the composition of the new compound as found is: C, 73.6%; H, 8.9%; O, 17.9%.
  • This product which has not been described heretofore and is new takes the form of colorless spangles orflakes which are insoluble in water, very soluble in benzene and chloroform, difficultly soluble in iso-propylic ether.
  • composition of the new compound as calculated is: C, 74.3%; H, 9.2%; O, 16.5%.
  • the composition of the new compound as found is: C, 74.3%; H, 9.2%; O, 16.8%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Description

STEROIDAL TRAN S-HEXAHYDROTEREPH- 'THALATE ESTERS Andre Allais, Paris, and Charles Hotlmann, Noisy le Grand, France, assignors to Les Laboratoires Francais dFe Chimiotherapie, Paris, France, a corporation of rance No Drawing. Filed July 6, 1956, Ser. No. 596,166 Claims priority, application France Aug. 26, 1955 5 Claims. (Cl. 260--397.4)
This invention relates to a method of preparing new ticularly to a method of preparing acylated derivatives of steroid hormones which are distinguished by prolonged activity and by satisfactory solubility in vegetable oils which are used as the injecting medium. The invention furthermore also relates to said acylated derivatives.
These new products are derived from trans-hexahydroterephthalic acid (POOH HOOC in which one of the carboxyl groups has been previously este'rified by an aliphatic alcohol.
With the above in view, it is an object of this invention to prepare new acylated derivatives of steroid hormones.
Another object of the invention is to provide a method of preparing oil soluble acylated derivatives of steroid hormones.
One further object of the invention is to prepare new products derived from trans-hexahydroterephthalic acid in which one of the carboxyl groups has been previously esterified.
Still another object of the invention is to provide new products of trans-hexahydroterephthalic acid containing the radical of a steroid hormone.
Other objects and features of the invention will become apparent from the following detailed'description and illustrations.
The compounds according to the invention, therefore, correspond to the formula:
ll C-OR in which R represents an alkyl radical and R, the radical of a steroid hormone. 7
According to the process of the present invention, the
new acylated derivatives are obtained according to meth- 2,959,601 Patented Nov. 8, 1960 ods known per se by the reaction of acid chloride ofa hexahydroterephthalic hemiester C-OR 1 with the steroid in the resence of a tertiar bas s acylated derivatives of steroid hormones, and more'paras pyridine, methylethyl pyridine or triethylamine, etc., the operation being carried. out at room temperature or In a heated state. The above noted reaction may be carried out with or without a suitable inert solvent such as benzene, toluene, ether, petroleum ether.
. bonate and then finally',.with water.
The reaction mixture is taken up with a solvent which is not miscible with water, is then washed with diluted mineral" acids 'such' as HCl, H HNO or Na CO K CO carbonate or sodium of potassium bicar- Afterdrying and distillation of the solvent, new crude mixed hexahydroterephthalates are obtained which are purified by crystallization of chromatography.
The starting acid chlorides as above shown which heretofore were unknown in the past and serve to acylate the steroids, are obtained from hexahydroterephthalic hemiesters than can easily be produced by monosaponification of the corresponding diesters. Also, they may-be prepared with less favorable yields, by hydrogenation of the corresponding terephthalic' monoester or by monoesterification of trans-hexahydroterephthalic acid. Thionyl chloride is considered most suitable for preparing the new acid chlorides. It is, of course, possible, without thereby exceeding the scope of the invention, to cause the new acid chlorides to react with a derivative of the steroid hormone and to prepare the mixed ester desired from the intermediate product obtained. For example, when preparing a 17 trans-hexahydroterephthalate of 17-hydroxyetiocholanone, it is then possible to brominate this compound at the 4-position and to dehydrobrominate with the formation of the desired ester of testosterone.
The new acylated derivatives maybe used dissolved in neutral vegetable oils, to which a glycol may or may not be added, or dissolved in other solvents suitable for injection purposes. The variable concentrations are limited by solubility only. The products, to the preparation of which the present invention relates, may be used in the form of thixotropic salts which are obtained by adding monostear ate or aluminum 2-ethyl hexanoate to the oily solutions of these esters. They may also bead ministtered in the form of microcrystalline aqueous suspensions or emulsions in water, solutions in a third solvent in the presence of a neutral and non-irritating emulsifying agent. The preparations are carried out by means of processes known per se.
The examples that follow herein are given asillus trations only and do'not nor are they intended to limit the scope of the invention. More particularly, it is possible to change the nature of the solvents, and of the condensing agent,- to work with or without suitable catalysts and to modify the temperature conditions without tion. v
In order to prepare hemiesters of trans-hexahydroterephthalic acids, it is, of course, possible directly to hydrogenate the previously esterified terephthalic acid.
When preparing mixed esters of the present invention it is, of course, possible first to prepare the transhexahydrophthalate of the steroid hormone selected and then to esterify the latter in the manner desired. It is equally possible to cause a hemiester of trans-hexahydroterephthalic acid to react with the steroid hormone in the presence of a suitable esterification catalyst thereby avoiding the use of the acid chloride.
EXAMPLE 1 Preparation of the acid chloride of n-butyl trans-hemihexahydroterephthalate ii C-OR wherein R=the n-butyl radical.
(a) PREPARATION OF DIMETHYLIC ESTER OF TEREPHTHALIC ACID This ester is prepared according to the method of Ullmann and Schlaepfer (Ber. dtsch. Chem. Ges., 1904, 37 2 002) esterifying terephthalic acid with methanol in the presence of sulfuric acid. Starting with 50 g. of terephthalic acid, 43 g. of the crude diester are obtained which are purified by recrystallization with acetone and treatment with charcoal. This produces 34 g. of dimethyl terephthalate, M.P.= 140.
(b) HYDROGENATION OF DIMETHYLIC ESTER OF TEREPHTHALIC ACID This is done according to the method of Fichter and Holbro (Helv. Chim. Acta, 1938, 21, 141) by hydrogenating the diester prepared according to (a) above in pure 99% acetic acid and in the presence of platinum oxide. Starting with 30.4 g. of methylic ester, and after absorption of practically the theoretical quantity of hydrogen, filtration of the solution in order to eliminate the. platinum oxide and evaporation of the acetic acid under vacuum, a light yellow oil is obtained formed by the mixture of the cis and trans-hexadydroterephthalic dirnethylic esters formed quantitatively. Thisproduct is sufiiciently pure to be transformed by hydrolysis into cis and trans-hexahydroterephthalic acids.
(0) PREPARATION OF TRANS-HEXAHYDROTEREPH- THALIC ACID This is done according to the method of Fichter and Holbro (Helv. Chim. Acta, 1938, 21, 141) by first hydrolyzing the mixture of the crude diester obtained according to (b) above with hydrochloric acid diluted to and by then rearranging the mixture of cis and transhexahydroterephthalic acids into trans-hexahydroterephthalic acid by heating with concentrated hydrochloric acid under pressure at a temperature of 125 for hours.
In order to hydrolyze the diester mixture, 49.2 g. of the crude product are heated with 492 cm. of 10% hydrochloric acid for 4 hours in a boiling water bath. The oil gradually changes into whitecrystals. Having been cooled, the product is centrifuged (desiccated), washed with water and again dried. The mother liquor supplies, by concentration, a second crop of the mixture of cis and trans-hexahydroterephthalic acids. The total yield is approximately 40 g.
29 g. of this isomeric mixture are heated in a sealed tube with 35 cm. of concentrated hydrochloric acid at 125 for 15 hours. The mixis then cooled afterwhich the tube is opened and the contents are centrifuged (desiccated), washed with a little ice Water, then made into paste twice with chloroform in order to remove any possible cis isomer residue which is very soluble therein and dried. From the above 27.4 g. of trans-hexahydroterephthalic acid are produced having a M.P.=above 300 C. (sublimation), or a yield of -9l%. The prod uct can be purified by recrystallizing in boiling water. ((1) PREPARATION OF n-DIBUTYLIC ESTER 0F TRANS HEXAHYDBO'IEREPHTHALIC ACID This compound is easily prepared by esterifying transhexahydroterephthalic acid prepared according to (c) above with n-butanol in the presence of concentrated sulfuric acid.
The following are mixed and heated on refluxing for 4 hours:
Trans-hexahydroterephthalic acid grams 26.8 Redistilled n-butanol ..vols 5 Concentrated sulfuric acid cm. 2
After 4 hours of boiling, the excess butanol is vacuum distilled, then taken up twice with benzene which is distilled each time. This produces a light-yellow oil which is dissolved in cm. of ether. The ethereal solution is washed twice with a solution of 5% sodium carbonate, then with water until the wash water is neutral. The solution is dried over sodium sulfate, the ether is distilled oif and the residue then taken up with light petroleum ether. This solution is filtered and evaporated until dry. The remaining oil is left to cool under refrigeration and then crystallized. This is centrifuged, and, after drying, there remain 43.5 g. (98%) of crude dibutylic ester having a M.P.=3032. The product distills completely under 0.5 mm. at 146-148 C. When cooled the distilled product crystallizes into colorless needles having the same melting point as before. It is soluble in alcohol, ether, petroleum ether, acetone, benzene and chloroform, insoluble in water, aqueous diluted acids and alkalis. This is a new compound having the following characteristics:
Saponification number as calculated 394 As found 387.5-389 (e) PREPARATION OF n-BUTYLIC HEMIESTER 0F TRANS HEXAHYDROTEREPHTHALIC ACID This compound is prepared by monosaponification of the diester prepared according to (d) above.
12.5 g. of potassium hydroxyde dissolved in 30 cm. of water are introduced, while stirring, into a solution of 56.9 g; of dibutyl ester in 435 cm. of n-butanol. The stirring is continued for four days at room temperature. The butanol is then distilled under vacuum and taken up three times with benzene which is distilled each time producing a White solid residue formed by the potassium salt of the desired hemister. This residue is dissolved in water. The aqueous solution is then washed twice with ether in order to extract the non-saponified diester and is then acidified with concentrated hydrochloric acid until it turns Congo red to blue. The n-butylic hemiester is then extracted with chloroform. A little diacid precipitates in the aqueous solution, from which it is separated by filtration. The chloroform solution is washed with water until neutral, then is dried over sodium sulfate and then distilled until dry. The residue is taken up with light petroleum ether which is removed under vacuum. The result obtained is an almost pure crystallized product having a melting point between 5556 C. The yield is about 66%. On the other hand, about 10% of the non-converted dibutyl ester is recovered from the ether, with which the aqueous solution of the potassium salt of the hemiester has been washed.
In order to purify the hemiester, it is dissolved in two volumes of petroleum ether whose boiling point range is 13:35 to 75 which is then cooled to 3040 C., and allowed to crystallize. The crystals are centrifuged (desiccated) at said temperature. The product assumes the shape. of small crystals with a M.P.=56.57 C. and
is soluble in organic solvents and dilutedalkalis, but insoluble in water and aqueous diluted acids.
Analysis of the product obtained shows the formula C H O with a molecular weight of 228.
The composition calculated is as follows: C, 63.1%; H, 8.8%; O, 28.9%. The composition as found is as follows: C, 63.2%; H, 8.9%; O, 28.4.
It is to be noted that the substance above with the formula given is a new compound.
(f) TRANSFORMATION OF THE n-BUTYLIC HEMIESTER F TRANS-HEXAHYDROTEREPHTHALIC ACID INTO ACID CHLORIDE Three gms. of n-butyl hemiester of trans-hexahydroterephthalic acid and 4.4 cm. of thionyl chloride are heated in a bath to 50 C, in the absence of moisture.
After one hour of heating, the temperature of the bath is solwly raised from 50 to 80 in 45 minutes. The excess thionyl chloride is then distilled and the distillate taken up twice with 5 cm. of anhydrous benzene, after which it is distilled. The residue is constituted by 3 g.
of the desired acid chloride, which is oily and of light yellow color.
Chemical analysis of the product above shows the formula of C H O Cl with a molecular weight of 246.7.
Percent The amount of calculated chlorine is 14.4 The amount found is 14.0
The products, therefore, comprise 97% of pure chloride which decomposes when its distillation is attempted. It is used, as is, for reaction with testosterone. This product is a new compound.
EXAMPLE 2 Preparation of the acid chloride of methyl transhexahydroterephthalate Trans-hexahydroterephthalic acid such as is prepared in Example 1, is esterified by means of methyl alcohol in lieu of butyl alcohol whose use was described hereinabove. The monosaponification of the dimethyl transhexahydroterephthalate is then carried out as above, but by treatment in methanol medium. The purified herniester is caused to react, as above, with the thionyl chloride thereby producing crude acid chloride which can be used directly for condensation with testosterone.
EXAMPLE 3 Preparation of acid chloride of isopropyl transhemihexahydroterephthalate wherein R=iso-propyl.
(a) PREPARATION OF THE DIESTER (b) PREPARATION OF THE'HEMIESTER' A solution formed by dissolving 12.9 grams of di-iso propyl ester of trans-hexahydroterephthalic acid in 105 cm. of pure iso-propanol, 2.8 g. of caustic'potassium hydroxyde and 3 cm. of water is heated to a temperature of about 60 C. for 2 hours. The resultant iso-propanol is eliminated by vacuum distillation, whereupon the residue is taken up with 150 cm. of water. Several cm. of a 10% sodium carbonate aqueous solution are thenadded until there is an alkaline reaction. The solution thus obtained is washed with ether, then acidified with concentrated hydrochloric acid and finally extracted with chloroform. The chloroform solution is washed with water, dried over magnesium sulfate and finally vacuum evaporated until dry.
According to the above method there are produced 6.7 grams (85%) of iso-propyl hemiester of trans-hexahydroterephthalic acid having a M.P.=88-89 C. on" the Maquenne block. This new product which has not been described heretofore, takes the form of colorless needles, insoluble in water but soluble in alcohol, ether, acetone, benzene and chloroform.
For purposes of analysis, it is recrystallized in 20 volumes of petroleum ether Eb. 35-75". Its analysis shows the formula as C H O having a molecular weight of 132.1.
The composition as calculated shows C, 61.7%; H, 8.5%; O, 29.8%. As found it shows C, 61.7%; H, 8.5%; O, 29.8%.
PREPARATION OF THE ACID CHLORIDE The procedure indicated under Example 1 (f) is followed by heating the hemiester inthe presence of thionyl chloride.
EXAMPLE 4 Preparation of the acid chloride of rl-ociyl trans hem i hexahydrotarephthalate II (J-OR Trans-hexahydroterephthalic acid ..grams 8 N-octyl alcohol cm. 40 Concentrated sulfuric acid cm. 0.6
This mixture is then cooled, neutralized by adding 2.5 g. of barium carbonate and filtered. One volume of ether is next added to the filtrate. It is washed with a 5% sodium carbonate aqueous solution, with water, dried over sodium sulfate and vacuum evaporated until dry. The residue supplies, after vacuum distillation, 12.6 grams (68%) of di-n-octyl ester of trans-hexahydro terephthalic acid. The last-named product which is new, takes-the'form of a colorless oil whose boiling range, Eb., under 0.8 mm. is 200-225 C. It is insoluble in water and soluble. in organic solvents. It is sufliciently pure for subsequent transformation into the hemiester which is given herein following.
(b) Preparation of the hemiester: A solution'consistingof 10 grams of n-octyl di-ester of trans-hexahydroterephthalic acid, 50 cm. of ,n-octyl alcohol, 1.51 g, of
then washed with ether, acidified with concentrated hydrochloric acid and extracted with chloroform. The chloroform solution is washed with water, dried over magnes um sulfate and vacuum evaporated until dry.
From the above procedure there are obtained 4.2 grams (58%) of n-octyl hemiester of trans-hexahydroterephthalic acid, having a M.P.=50 C. on the Maquenne block. This product, which has not been described or known heretofore, is crystalline in shape, insoluble in water, but soluble in organic solvents such as alcohols, benzene, chloroform. To be analyzed, it is recrystallized in 1 volume of petroleum ether having a boiling point Eb. 35-75".
Its chemical analysis shows the formula as C H O and the molecular weight as 284.2.
Its composition as calculated is: C, 67.6%; H, 9.9%; O, 22.5%. As found C, 67.8%; H, 10.1%; 0, 22.7%.
(c) The preparation of the acid chlorides is effected by proceeding as indicated under Example 1 (f), by heating the hemiester in the presence of thionyl chloride.
Example 5 Preparation of mixed n-butyl and testosterone transhexahydroterepht-halate:
C-OR
wherein R=n-butyl radical and R'= 2 grams of testosterone are dissolved in 3 cm of pyridine. 2.1 grams of acid chloride of the hexahydroterephthalic n-butylic hemiester prepared according to Example 1, are dissolved in 2 cm. of benzene, are slowly added to the above solution while stirring and cooling the flask by means of an ice bath. The reaction is exothermic, from which pyridine hydrochloride quickly precipitates. The reaction mixture which has taken on a pink color is left standing for 24 hours. It is then stirred or shaken for minutes with cm; of water in order to destroy the excess acid chloride, and is then extracted with iso-propylic ether. The ethereal solution is washed with hydrochloric acid, then with sodium carbonate and finally with water until neutral. It is dried over sodium sulfate, and the ether is expelled. There results a crystallized residue melting at about 95 C. formed by the crude mixed ester. Subjected to chromatography in benzene solution over alumina, one obtains, by washing out with the same solvent, a fraction melting between 70 and 95 C. A second washing or eluate obtained with benzene comprising 10% ethyl ether melts between 100 and 110.
A second chromatography carried out separately on each of these fractions results in the same principal product having a M.P.=110, with a total yield of about 60%. This product is formed by the desired mixed n-butyl and testosterone trans-hexahydroterephthalate. The melting point does not go up after recrystallization in petroleum ether whose boiling point B is 5070 followedby a new crystallization in 50% ethanol. The
8 product takes the form of small colorless crystals with a M.P. of 110, /oc/ =81.5 (c.=1%, ethanol). It is very soluble in all organic solvents except petroleum ether. Its solubility in olive oil is 10% which compares favorably with that of the other esters of testosterone.
Its chemical analysis shows the formula of C H O and the molecular weight of 498.6.
The composition as calculated is: C, 74.66%; H, 9.29%; O, 16.04%. The composition as found is: C, 74.9%; H, 9.3%; O, 16.3%. This is a new compound.
When this compound is tried out on the castrated male rat in the test of modifying the weight of the seminal vesicles at the docs corresponding to 17 mg. of testosterone, or 30 mg. of the product, it is found that the average weight of the vesicles at the end of 10 days is 635 mg., at the end of 17 days, 666 mg, and at the end of 24 days 621 mg.
If an equivalent dose of testosterone propionate is administered, namely, 20.8 mg., the respective weights are 299, 48 and 30 mg., which proves that the new prodnot has a greater as well as more prolonged activity. Using testosterone oenanthate, always at a dose equivalent of 17 mg. of testosterone, namely, 24.1 mg. of oenanthate, the corresponding figures are 452, 514 and 465 mg. Even in this case the superiority of the new product is clearly established.
EXAMPLE 6 Preparation of mixed n-butyl and estradiol trans-hexahydroterephthalate wherein R=n-butyl radical and R:
1.25 g. of n-butylic hemiester of trans-hexahydroterephthalic acid prepared according to Example 1 above and 5 cm. of thionyl chloride are heated under reflux conditions for half an hour. The excess chlorinating agent is expelled under vacuum, whereupon the residue is taken up with 6 cm. of benzene, then cooled to 10 C. and poured into a solution of 1.14 g. of estradiol 3- monoacetate in 5.7 cm. of pyridine which has been cooled to 10 C. This mix is then left for two hours at room temperature, after which 1 cm. of water is added. It is then poured into N hydrochloric acid and extracted with chloroform. The combined extracts are washed with water, with N/S sodium hydroxyde, dried over magnesium sulfate and vacuum evaporated until dry. The residue is taken up with 40 cm. of ethanol, to which 0.5 cm. of caustic sodium hydroxyde is added. It is then left to stand for half an hour at 20 C. then poured into water, acidified with concentrated hydrochloric acid and extracted with ether. The combined ethereal extracts are dried, then evaporated until dry.
By the above reactions there is produced a colorless residue which crystallizes when taken up with methanol. The yield is 1.1 g. (60%) n-butyl and EXAMPLE 7 Preparation of mixed n-butyl and cortisone trans-hexahydroterephthalate wherein-R=n-butyl radical and R:
' CHzO- The procedure under this example is the same as in the preceding example. l g. of n=butyl hemiester of transhexahydroterephthalic acid, 4 cm. of thionyl chloride,
the acid chloride being taken up with 5 cm. of benzene,
and 1 g. of cortisone in 5 cm. of pyridine are mixed together at room temperautre.
When the reaction is complete, 1 cm. of water is then added, and the resultant solution poured into N hydrochloric acid. The product is extracted with chloroform, then washed with water, with N soda, again with water, and then dried over magnesium sulfate and evaporated until dry. The residue is taken up with a mixture of 60 cm. of ethanol and 6 cm. of chloroform. To this is added a solution of 150 mg. of sodium periodate and 1.5 cm. of N sulfuric acid in 10 cm. of water, and the mix is left undisturbed for half an hour at 25 C. The whole mix is then poured into water and extracted with chloroform. The extract is washed with water and dried over magnesium sulfate. The chromatography is carried out over 40 g. of neutral alumina. Elution with a 10%-methanol chloroform produces, after evaporation until dry and crystallization occurs in aqueous acetone, 750 mg. (50%) of n-butyl and cortisone trans-hexahydroterephthalate, having a M.P.=189 C., /Ot/ +l48i2 (c.=0.5% acetone). This resultant product which is new, takes the form of colorless spangles or flakes which are insoluble in water, diificultly soluble in alcohol and ether, soluble in acetone, benzene and chloroform.
The chemical analysis shows the formula to be C H O whose molecular weight is 570.7.
The composition is calculated as: C, 69.4%; H, 8.1%; O, 22.4%. The composition as found: C, 69.2%; H, 8.2%; O, 22.8%.
, 0 EXAMPLE 8 Preparation of mixed n-butyl and prednisone trans-hexahydroterephthalate it C-OR Ill-E wherein R=n-butyl radical and R:
CHaO- The procedure herein is substantially the same as in Example 6.
..1.5 g. of n-butylic hemiester of trans-hexahydroterephthalic acid, 6 cm. of thionyl chloride, the acid chloride being taken up with 7.5 cm. of benzene, and 1.5 g. of
prednisone, or A -dehydrocortisone, in 7.5 cm. of py-ridine are mixed together at room temperature.
When the reaction is complete, 1 cm. of water is added. The whole mix is'poured into N hydrochloric acid and then extracted with chloroform. The combined extracts are washed with water, with N sodium hydroxide, dried over magnesium sulfate, and the chromatography thereof is carried out over 40 g. of neutral alumina. Elution with chloroform produces, after evaporation until dry, .and crystallization in ether, 800 "mg. (50%) of n-butyl and prednisone trans-hexahydroterephthalate having the following characteristics: M.P.=189 C., /oc/ =|140i2 (c.=0.5% acetone).
This product which has not been described heretofore and which is new is in the form of colorless spangles or flakes. It is insoluble in water, difficultly soluble in ether, but soluble in alcohol, acetone, benzene and chloroform.
The chemical analysis of thecompound shows the formuIa of C H O and a molecular weight .of 568.7.
f The composition as calculated is: C, 69.7%; H, 7.8%. The composition as found is: C, 69.8%; H, 8.0%.
EXAMPLE 9 Preparation of mixed methyl and testosterone trans-hexai hydroterephthalate i (ll-OR wherein R=methyl radical and R:
The procedure herein is as in Example 5. 1 g. of methylic hemiester of trans-hexahydrotereph- 11 thalic acid prepared according to Example 2 herein, 4 cm. of thionyl chloride, the acid chloride being taken up with 5 cm. of benzene and 1 g. of testosterone in 5 cm. of pyridine are mixed together at room temperature.
After the reaction is completed, 1 cm. of water is added. This mixture is then poured into N hydrochloric acid and then extracted with chloroform. The combined extracts are washed with water, with N sodium hydroxide solution, dried over magnesium sulfate and then vacuum evaporated until dry. The residue thus obtained is recrystallized in aqeous methanol to produce 1.1 g. 70% strength of methyl and testosterone transhexahydroterephthalate having the following characteristics: M.P.=161 C., /oc/ =+96i2 '(c.=0.5%, chloroform) This product which is new takes the form of colorless spangles or flakes which are insoluble in water, soluble in alcohol, ether, acetone, benzene and chloroform.
The chemical analysis of the compound shows the formula of C H O with a molecular weight of 456.6. The composition of the new compound as calculated is: C, 73.6%; H, 8.8%; O; 17.5%. The composition of the new compound as found is: C, 73.6%; H, 8.9%; O, 17.9%.
EXAMPLE Preparation of mixed isopropyl and testosterone transhexahydroterephthalate l? C-OR wherein R=isopropyl radical and R= The procedure herein is the same as in Example 5.
1.5 g. of iso-propylic hemiester of trans-hexahydroterephthalic acid prepared according to Example 3, 6 cm. of thionyl chloride, the acid chloride being taken up with 6 cm. of benzene and 1 g. of testosterone in 5 cm. of pyridine are mixed together at room temperature.
When the reaction is completed, the benzene solution is washed with water, with 2 N hydrochloric acid, again with water and then with sodium bicarbonate, with water, the product is dried over magnesium sulfate, and the chromatography is carried out over 30 g. of neutral 12 alumina. Elution with ether supplies, after evaporation until dry and crystallization in isopropylic ether, 500 mg. (30%) of isopropyl and testosterone trans-hexahydroterephthalate having the following characteristics: M.P.==156157 C., /oz/ =+89i2 (c.=0.5%, chloroform).
This product which has not been described heretofore and is new takes the form of colorless spangles orflakes which are insoluble in water, very soluble in benzene and chloroform, difficultly soluble in iso-propylic ether.
The chemical analysis of the compound above shows the formula of C H O with a molecular weight of 484.6.
The composition of the new compound as calculated is: C, 74.3%; H, 9.2%; O, 16.5%. The composition of the new compound as found is: C, 74.3%; H, 9.2%; O, 16.8%.
From the foregoing description taken in conjunction with the accompanying illustrative examples, it will be noted that there has been provided a novel method of preparing acylated derivatives of steroid hormones for medicinal use. It will be also noted that there are provided according to the invention new products derived from trans-hexahydroterephthalic acid which are highly useful in veterinary medicine.
While preferred methods have been described, it is to be understood that modifications in procedure, use of material and their arrangement may be made without departing from the spirit and scope of the invention as claimed.
We claim:
1. As a new product, the 17-estradiol ester of transhexahydroterephthalic acid mono-n-butyl ester.
2. As a new product, the testosterone ester of transhexahydroterephthalic acid mono-n-butyl ester.
3. As a new product, the 21-cortisone ester of transhexahydroterephthalic acid mono-n-butyl ester.
4. As a new product, the 21-prednisone ester of transhexahydroterephthalic acid mono-n-butyl ester.
5. As a new product, the testosterone ester of transhexahydroterephthalic acid mono-isopropyl ester.
References Cited in the file of this patent UNITED STATES PATENTS 2,070,770 Amend Feb. 16, 1937 2,183,589 Reichstein Dec. 19, 1939 2,384,955 Moyle Sept. :18, 1945 2,551,575 Martin May 8, 1951 2,653,955 Rogers Sept. 29, 1953 2,655,527 Hogg Oct. 13, 1953 2,746,978 Ott May 22, 1956 2,751,402 Schneider June 19, 1956 2,755,292 Leslie July 17, 1956 2,781,368 Heyl et al. Feb. 12, 1957 2,783,226 Gould Feb. 26, 1957 2,794,036 Kasper et a1. May 28, 1957 2,813,880 Campbell et al Nov. 19, 1957 2,837,464 Nobile June 3, 1958 the q

Claims (1)

  1. 2. AS A NEW PRODUCT, THE TESTOSTERONE ESTER OF TRANSHEXAHYDROTEREPHTHALIC ACID MONO-N-BUTYL ESTER.
US596166A 1955-08-26 1956-07-06 Steroidal trans-hexahydroterephthalate esters Expired - Lifetime US2959601A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR2959601X 1955-08-26

Publications (1)

Publication Number Publication Date
US2959601A true US2959601A (en) 1960-11-08

Family

ID=9690349

Family Applications (1)

Application Number Title Priority Date Filing Date
US596166A Expired - Lifetime US2959601A (en) 1955-08-26 1956-07-06 Steroidal trans-hexahydroterephthalate esters

Country Status (1)

Country Link
US (1) US2959601A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3525755A (en) * 1964-11-25 1970-08-25 Schering Ag Process of preparing polycarboxylic acid esters of tertiary 17-steroid alcohols

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2070770A (en) * 1935-10-18 1937-02-16 Du Pont Hydrogenation of alkyl phthalates
US2183589A (en) * 1939-12-19 Derivatives of compounds of the
US2384955A (en) * 1941-10-01 1945-09-18 Dow Chemical Co Esters of 4-cyclohexene-1, 2-dicarboxylic acid
US2551575A (en) * 1946-10-12 1951-05-08 Publicker Ind Inc Esters of sulfo-4-cyclohexene-1, 2-dicarboxylic acid and process for producing same
US2653955A (en) * 1951-08-09 1953-09-29 Merck & Co Inc Cortisone esters and process
US2655527A (en) * 1951-02-24 1953-10-13 Upjohn Co Carbethoxycyclohexanones
US2746978A (en) * 1951-09-01 1956-05-22 Upjohn Co Cortisone, 21-beta-cyclopentyl-propionate
US2751402A (en) * 1953-08-13 1956-06-19 Upjohn Co Oxidation of hydrocortisone esters to cortisone esters
US2755292A (en) * 1952-01-21 1956-07-17 Organon Labor Ltd Phenyl propionate of testosterone
US2781368A (en) * 1953-01-15 1957-02-12 Upjohn Co 11-ketotestosterone, 11-keto-19-nortestosterone, esters thereof and process
US2783226A (en) * 1955-02-03 1957-02-26 Schering Corp Esters of cortical hormones
US2794036A (en) * 1953-11-21 1957-05-28 Schering A G Fa Cortisone-undecylate
US2813880A (en) * 1956-06-14 1957-11-19 Upjohn Co 4, 4-dialkyl androstenes and method
US2837464A (en) * 1955-01-11 1958-06-03 Schering Corp Process for production of dienes by corynebacteria

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2183589A (en) * 1939-12-19 Derivatives of compounds of the
US2070770A (en) * 1935-10-18 1937-02-16 Du Pont Hydrogenation of alkyl phthalates
US2384955A (en) * 1941-10-01 1945-09-18 Dow Chemical Co Esters of 4-cyclohexene-1, 2-dicarboxylic acid
US2551575A (en) * 1946-10-12 1951-05-08 Publicker Ind Inc Esters of sulfo-4-cyclohexene-1, 2-dicarboxylic acid and process for producing same
US2655527A (en) * 1951-02-24 1953-10-13 Upjohn Co Carbethoxycyclohexanones
US2653955A (en) * 1951-08-09 1953-09-29 Merck & Co Inc Cortisone esters and process
US2746978A (en) * 1951-09-01 1956-05-22 Upjohn Co Cortisone, 21-beta-cyclopentyl-propionate
US2755292A (en) * 1952-01-21 1956-07-17 Organon Labor Ltd Phenyl propionate of testosterone
US2781368A (en) * 1953-01-15 1957-02-12 Upjohn Co 11-ketotestosterone, 11-keto-19-nortestosterone, esters thereof and process
US2751402A (en) * 1953-08-13 1956-06-19 Upjohn Co Oxidation of hydrocortisone esters to cortisone esters
US2794036A (en) * 1953-11-21 1957-05-28 Schering A G Fa Cortisone-undecylate
US2837464A (en) * 1955-01-11 1958-06-03 Schering Corp Process for production of dienes by corynebacteria
US2783226A (en) * 1955-02-03 1957-02-26 Schering Corp Esters of cortical hormones
US2813880A (en) * 1956-06-14 1957-11-19 Upjohn Co 4, 4-dialkyl androstenes and method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3525755A (en) * 1964-11-25 1970-08-25 Schering Ag Process of preparing polycarboxylic acid esters of tertiary 17-steroid alcohols

Similar Documents

Publication Publication Date Title
US2735855A (en) Process for producing a
US2332815A (en) Compounds of the hormone series
US2753357A (en) Lactones of 1, 12-dimethyl-6, 10-dihydroxy-9-oxo-1, 2, 3, 4, 9, 10, 11, 12-octahydrophenanthrene-1-carboxylic acid
US2959601A (en) Steroidal trans-hexahydroterephthalate esters
US2918463A (en) 17-carboxyalkylated 17-hydroxy-19-norandrosten-3-ones
US2305727A (en) Compounds of the cyclopentanopolyhydrophenanthrene series and process of making same
US2786843A (en) Tetkadehydro reserpic acid and esters
US2205627A (en) Esters of unsaturated polyhydroxy estrane
US2308834A (en) Polynuclear cyclic oxyketones and derivatives thereof and process of making same
US3030391A (en) 12-alkoxy-11-oxygenated pregnanes
US2357224A (en) Process for the manufacture of esters of the suprarenal cortical hormone series
US2249911A (en) Cyclopentan opolyhydrophenanthrene derivatives and process of producing same
US2098984A (en) Dehydro-sterol compounds and manufacture thereof
US2422904A (en) Method of preparing delta1,4-androstadienol-17-one-3 and its derivatives
US2750381A (en) Steroid alkali-metal enolates
USRE22941E (en) X-substituted
US2923709A (en) 17-substituted derivatives of 1, 11-epoxy-4-methyl-1, 3, 5(10), 9(11)-estratetraene
US3006928A (en) 19-nor-testerone-17-transhexahydro-terephthalate
US3176032A (en) 17alpha, 21-diacyloxy derivatives of 6alpha-methyl-delta1, 4-pregnadien-3, 20-dione and of 6alpha-methyl-delta4-pregnen-3, 20-dione
US2248438A (en) Enol derivatives of cyclopentano phenanthrene compounds and process of making same
US3153061A (en) 17-substituted 2, 5-pregnadiene derivatives
US2932641A (en) Alpha, beta-butenolides of the pregnene, pregnane and allopregnane series and a process for preparing them
US2809198A (en) Tetradehydrodeserpidic acid compounds
US2870142A (en) Process for the partial removal of oxo groups
US3026335A (en) 17-esters of 16alpha, 17alpha-dihydroxyprogesterone